The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer
Jeong‐Yeol Park
Abstract
Open-access reader
Jeong‐Yeol Park
Abstract
Open-access reader
The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer ► See the article "Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers" in volume 31, e10.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer ► See the article "Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers" in volume 31, e10.
Key concepts: Medicine, Venous thromboembolic disease, Thromboembolic disease, Gynecologic cancer, Venous thromboembolism, Cancer, Venous thrombosis, Intensive care medicine